Navigation Links
XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
Date:8/28/2007

NEW YORK, August 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and hepatitis C, today announced the receipt on August 23, 2007, of a NASDAQ Staff Deficiency Letter indicating that, according to the Company's financial statements for the six months ended June 30, 2007, XTL no longer complies with the minimum $10 million shareholders' equity requirement for continued listing on The NASDAQ Global Market as set forth in Marketplace Rule 4450(a)(3).

The Company intends to respond to NASDAQ with information that may enable the Company to maintain its listing on The NASDAQ Global Market; however, if the Company's plan for compliance is not satisfactory, the Company has the option to transfer its ADR listing to the NASDAQ Capital Market, previously called the NASDAQ SmallCap Market.

The NASDAQ Capital Market is a continuous trading market that operates in the same manner as The NASDAQ Global Market. The NASDAQ Capital Market is not related to, nor does it operate similarly to the over-the-counter markets including the OTCBB and Pink Sheets. Should the Company transfer its ADR listing to The NASDAQ Capital Market, its trading symbol on NASDAQ would remain "XTLB," and the Company does not expect any interruption in the trading of its ADRs.

The NASDAQ Capital Market includes over 500 issuers of a wide range of capitalization sizes. A NASDAQ Capital Market security satisfies all applicable qualification requirements for NASDAQ securities, and all companies listed on The NASDAQ Capital Marke
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...SHINGTON, Nov. 9 The Ap...n Humanist Association, held a panel discussion to...rsial emerging technologies in biomedical sciences...athan Moreno and Andrew Light, both of the Center ...rom ethical and political angles. ,, A video o...
(Date:11/9/2009)... SHANGHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma...ir evolution. The companies are facing significan...ocketing R&D costs, calls for,lower prices and...ether with,the financial crisis have made the work...aceutical companies are being forced to globalize ...
(Date:11/9/2009)... LONDON, November 9 Following the...US Food and Drug Administration (FDA), privately,o...://www.davalinternational.com ) has been informed ...O(R) has been awarded an Orphan-Drug,designation f...(ALS). , ALS, also known as Lou Gehrig,s ...
(Date:11/6/2009)...NBROOK, N.Y., Nov. 6 Bio...iopharmaceutical company developing first-in-class...inancial results for the third quarter ended Septe...t, in September of this year, the FDA,s Arthritis ...ote of 12-0, the approval of XIAFLEX(TM) for the t...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...rlands, April 8 Amsterdam,Molecular Therapeutics ...ne,therapy, is, as of today, part of the newly cre...pleased that NYSE Euronext has selected our compan... "The index will increase,the visibility of listed...k,the performance of our sector.", The index is p...
...RNewswire/ - The PerOs team is proud to announce,t...ense for the production,of bacterins as well as an...d oral delivery formulation methods (Oralject(TM))...d our oral vaccine,formulation platform in the Uni...ompany, and we look forward offering these capabil...
... Board of Molecular Vision today,announces that di...sition,of Molecular Vision have now ceased. Acrong...nd timetable agreed. Given this, the Board of,Mole...he company are served,by bringing these discussion...cant shareholder in Molecular Vision, having recen...
Other Biology Technology:Amsterdam Molecular Therapeutics Part of Next Biotech Index 2PerOs obtains USDA Establishment and Product Licenses for it's oral vaccine formulations 2
(Date:11/9/2009)...nia and elsewhere provide support for the use of m...d protecting marine habitats, according to biologi..., A recent study in the Gulf of California, for ...ehind marine reserves--the idea that offspring pro... of harvested species outside the reserve. , "It...
(Date:11/9/2009)...ad their hands tied because more than half of all ...n called p53. As a critical anti-cancer watchdog, ... within cells. When cells lose p53, tumors grow ag... tumors might be tough, but they,re not invincible...oratory (CSHL). The chink in the tumors, armor, ac...
(Date:11/9/2009)...researchers has completed a first draft of the cas... important first step in accelerating the pace of ...ome of the many limitations that face cassava farm...hat serves as the primary food source for more tha...y properties that make it an important food across...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 1Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 2Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 3HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 51697 1HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 51697 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 1YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 3
...tute of Standards and Technology (NIST), in suppor...on Research Network (EDRN), has validated the meas...ondrial DNA as an early indicator for certain type...atively simple diagnostic test using a DNA microar...lid tumors, including lung cancer. , Mitochondrial...
...es beneath the living brain,s surfaceResearchers a...g, minimally invasive optical technique that can c... of live subjects. The method, called two-photon m... and mechanical techniques into one device that fi...the September 1, 2005 issue of Optics Letters, a j...
...olinium (brand name: Xcytrin, manufactured by Phar...isrupting key enzymes involved in cellular metabol...eph Hacia, Ph.D., assistant professor of biochemis...dicine of the University of Southern California. ,...he amount of zinc available inside the cancer cell...
Other Biology News:Microscopic brain imaging in the palm of your hand 2Microscopic brain imaging in the palm of your hand 3USC researchers determine mechanism of action of chemotherapy drug 2
ChemiArray Mouse Lysate Cytokine Antibody Array III, 62 cytokines per membrane from CHEMICON
50 ml Magnetic Separation Rack from New England Biolabs
ChIP-GLAS-H10K-B from Aviva Systems Biology
TOPO Shotgun Subcloning Kit from Invitrogen
Biology Products: